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EDITORIAL POLICY AND GENERAL INFORMATION
The Reports of Practical Oncology and Radiotherapy is
aninterdisciplinary bimonthly journal, publishing origi-
nal contributions in clinical oncology and radiotherapy,
aswell as in radiotherapy physics, techniques and radio-
therapy equipment.
The Reports of Practical Oncology and Radiotherapy
is issued 6 times per year on paper and in electronic
form at www.rpor.eu. Reports of Practical Oncology
and Radiotherapy is internationally indexed in
EMBASE/Excerpta Medica Database, the Elsevier
BIOBASE (Current Awareness l in Biological
Sciences) and in the Index Copernicus.
Rep. Pract. Oncol. Radiother. editors endorse the
principles embodied in the Declaration of Helsinki
and expect that all investigations involving humans
will have been performed in accordance with these
principles. For animal experimentation reported
in the journal, it is expected that investigators will
have observed the Interdisciplinary Principles and
Guidelines for the Use ofAnimals in Research, Testing,
and Education issued by the New York Academy df
Sciences Adhoc Committee on Animal Research. All
human and animal studies must have been approved
by the investigator's Institutional review board.
Review process. Manuscripts are evaluated on the basis
that they present new insights to the investigated topic,
are likely to contribute to a research progress or change
in clinical practice or in thinking about a disease. It
is understood that all authors listed on a manuscript
have agreed to its subffiission. The signature of the
corresponding author on the letter of submission
-signifies that these conditions have been fulfilled.
Received manuscripts are first examined by the
Rep. Pract. Oncol . Radiother. ' editors. Manuscripts
with insufficient priority for publication are rejected
promptly. Incomplete packages or manuscripts not
prepared in the advised style will be sent back to
authors without scientific review. The authors are
notified with the reference number upon manuscript
registration at the Editorial Office. The registered
manuscripts are sent to independent experts for
scientific evaluation. We encourage authors to suggest
the names of possible reviewers, but we reserve the
right of final selection. The evaluation process usually
takes 1-3 weeks. Submitted papers are accepted for
publication after a positive opinion of the independent
reviewers.
Cenflict of Interests. Authors of research articles
should disclose at the time of submission any
financial arrangement they may have with a company
whose product figures prominently in the submitted
manuscript or with a company making a competing
product. Such information will be held in confidence
while the paper is under review and will not influence
the editorial decision, but if the article is accepted for
publication, the editors will usually discuss with the
Instruct ions fo r authors
authors the manner in which such information is to be
communicated to the reader.
Because the essence of reviews and editorials is
selection and interpretation of the literature, Rep.
Pract. Oncol. Radiother. expects that authors of
such articles will ' not have any financial interest in
a company (or its competitor) that makes a product
discussed in the article.
Rep. Pract. Oncol. Radiother. policy requires that
reviewers, co-editors, editorial board members reveal
in a letter to the Editor-in-Chief any relationships that
they have that could be construed as causing a conflict
of interest with regard to a manuscript under review.
The letter should include a statement of any financial
relationships with commercial companies involved
with a product under study.
Permissions. Materials taken from other sources
must be accompanied by a written statement from
both author and publisher giving permission to Rep.
Pract. Oncol. Radiother. for reproduction. Obtain
permission in writing from at least one author of
papers still in press, unpublished data, and personal
communications.
Patients confidentiality. Changing the details of
patients in order to disguise them is a form of data
alteration. However authors of clinical papers are
obliged to ensure patients privacy rights. Only
clinically or scientifically important data are permitted
for publishing. Therefore, if it is possible to identify a
patient from a case report, illustration or paper, Editors
of Rep . Pract. Oncol. Radiother. ask for a written
consent of the patient or his/her guardian to publish
their data, including photograms prior to publication.
The description of race, ethnicity or culture of a study
subject should occur only when it is believed to be of
strong influence on the medical condition in the study.
When categorizing by race, ethnicity or culture, the
names should be as illustrative as possible and reflect
how theses groups were assigned.
Copyright transfer. Upon acceptance, authors transfer
copyrights to the Reports of Practical- Oncology
and Radiotherapy. Once an article is accepted for
publication in . Rep. Pract. Oncol. Radiother., the
information therein is embargoed from reporting by
the media until the mail date of the issue in which the
article appears.
Upon acceptance all published manuscripts become
the permanent property of the Great Poland Cancer
Centre, the Publisher of Reports of Practical
Oncology and Radiotherapy, and may not be published
elsewhere without written permission from the Great
Poland Cancer Centre.
Disclaimer. Every effort is made by the Editor-in-
Chief and the Editorial Board of Rep. Pract. Oncol.
Radiother. to see that no inaccurate or misleading
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data, opinion or statement appear in the Reports
of Practical Oncology and Radiotherapy. However,
they wish to make it clear that the data and opinions
appearing in the articles and advertisements herein
are the responsibility of the contributor, sponsor or
advertiserconcerned. Accordingly, the Editor-in-Chief
and the Editorial Board accept no liability whatsoever
for the consequences of any such inaccurate of
misleading data, opinion or statement. Every effort is
made to ensure that drug doses and other quantities
are presented accurately. Nevertheless, readers are
advised that methods and techniques involving drug
usage and other treatments described in the Rep.
Pract. Oncol. Radiothen, should only be followed in
conjunction with the drug or treatment manufacturer's
own published literature in the readers own country.
/'
Publishing model. Reports of Practical Oncology
and Radiotherapy is published using the open access
model. All original scientific content [research articles,
case reports, product investigations] are available
free of charge without restrictions from the journal's
Website at: www.rpor.eu. The submission, review and
publication of manuscripts are free'of charge.
CRITERIA FOR MANUSCRIPTS
Editorial Board of Reports of Practical Oncology
and Radiotherapy takes under consideration for
publication original articles with the understanding
that neither the manuscript nor any part of its essential
substance, tables or figures have been published
previously "in print form or electronically and are
not under consideration by any other publication or
electronic medium. This restriction does not apply
to abstracts or press reports published in connection
with scientific meetings. Copies of any closely related
manuscripts should be submitted to the Editor along
with the manuscript that is to be considered by the
Rep. Pract. Oncol. Radiother.
The Rep. Pract. Oncol. Radiother. discourages the
submission of more than one article dealing with
related aspects of the same study.
Each submission packet should include the statement
signed by the first author that the work has not been
published previously or submitted elsewhere tor
review and a copyright transfer.
CATEGORIES OF ARTICLES
Accepted papers are published in the following
journal sections:
- original papers (not more than 10 pages)
- review articles (not more than 8 pages)
- preliminary communications for rapid
communication of preliminary data (not more than
4 pages) ,
- technical notes (not more than 2 pages)
- letters to the Editor for comments on recent
articles (not more than 1 page)
- case reports (not more than 8 pages)
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PREPARATION OF MANUSCRIPT
Guidelines for submission in Reports of Practical
Oncology and Radiotherapy are in accordance with:
Uniform Requirements for Manuscripts Submitted
to Biomedical Journals (N Eng J Med, 1997; 336:
309-15) .
The manuscript should be typewritten on a white
paper of the size ISO A4 (210x297 mm) . The text
should be processed on the laser or inkjet printer
preferably, or on a typewriter; in the last case,
however, the authors are requested to take care about
the quality of printing tape. Text should be one and
halt spaced with 12-point typeface. Margins: 2.5 em
(1 inch) at top, bottom, right, and left.
Illustrations are very helpful and for case reports
are mandatory. In reviews it should be explained
what information retrieval sources were used and
what were the criteria in selecting the referred
papers.
The Editorial Board reserves the privilege to adjust
the format of the article.
-,
The manuscript should include:
Title page with the following information:
- full names of all authors
- name of the department and institution in which the
work was done affiliations of the authors
- manuscript full title
- running title
- full .name, address, telephone and/or fax number of
the author responsible for manuscript preparation
- e-mail address to speed up contacts with authors
- sourcejs) of support in the form of grants (quote the
number of the grant) equipment, drugs etc.
Summary page. SUMMARY in structured form not
exceeding 250 words should consist of five paragraphs
labeled: Aim, Background, Materials and Methods,
Results, Conclusion. Each summary section should
begin in a new line and briefly.describe, respectively,
the purpose of the study, how the investigation was
performed, the most important results and the
principal conclusion that authors draw from the
results.
KEY WORDS (3 to 6) or short phrases should be
written at the bottom of the page including summary.
The use ' of the items included in Index Medicus
(Medical Subject Headings) is advised.
Text. Thetext of the article should be divided to eight
paragraphs labeled: Background, Aim, Materials
and Methods, Results, Discussion, Conclusions,
Acknowledgements, References.
Background should contain scientific rationale and
the aim of the study or (in case of a review) the
purpose of the article.
Materials and methods should describe clearly the
selection of observational or experimental subjects
(patients or laboratory animals) including controls,
such as age, gender, inclusion and exclusion criteria,
(the circumstances tor rejection from the study should
be clearly defined), randomization and masking
(blinding) method.
The protocol of data acquisition, procedures,
investigated parameters, methods of measurements
and apparatus should be described in sufficient detail
toallow other scientists to reproduce the results. Name
and references to the established methods should be
given . References and brief description should be
provided for methods that have been published but
are not well known, whereas new or substantially
modified methods should be described in detail. The
reasons for using them should be provided along with
the evaluation of their limitations. The drugs and other
chemicals should be precisely identified including
generic name, dose and route oft administration.
The statistical methods should be described in detail
to enable verification of the reported results.
Provide information on patient's informed consent.
Studies on patients and volunteers require informed
consent documented in the text of the manuscript.Where
there is any unavoidable risk of breach of privacy - e.g.
in a clinical photograph or in case details - the patient's
written consent to publication must be obtained and
copied to the journal. Information on approval of a local
Ethical Committee should also be provided.
Results should concisely and reasonably summarize
the findings . Restrict tables and figures to the number
needed to explain the argument of the paper and
assess its support. Do not duplicate data in graphs
and tables. Give numbers of observation and report
exclusions or losses to observation such as dropouts
from a clinical trial. Report treatment complications.
The results should be presented in a logical sequence
in the text, tables and illustrations. Do not repeat in the
text all the data from the tables or graphs. Emphasize
only important observations.
Discussion should deal only with new and/or important
aspects of the study. Do not repeat in detail data or
other material from the Background or the Results
section. Include in the Discussion the implications
of the findings and their limitations, including
implications for future research. The discussion
should confront the results of other investigations
especially those quoted in the text.
Conclusions should be linked with the goals of the
study. State new hypotheses when warranted . Include
recommendations when appropriate. Unqualified
statements and conclusions not completely supported
by the obtained data should be avoided.
Acknowledgements. List all contributors who do not
meet the criteria tor authorship, such as technical
Instructions for Auth ors
assistants, writing assistants or head of department
who provided only general support. Financial and
other material support should be disclosed and
acknowledged.
References must be numbered consecutively as they
are cited. References selected for publication should
be chosen tor their importance, accessibility, and tor
the "furt her reading" opportunities they provide.
References first cited in tables or figure legends must
be numbered 50 that they will be in sequence with
references cited in the text. The style of references is
that of Index Medicus. List all authors when there are
six or fewer; when there are seven or more, list the first
three, then "et al" . The following is a sample reference:
Standard journal article
Lahita R, Kluger J, Drayer DE et al: Antibodies to
nuclear antigens in patients treated with procainamide
or acetylprocainamide. N Engl J Med, 1979; 301:
1382-85
Article with published erratum
Koffler D, Reidenberg MM: Antibodies to nuclear
antigens in patients treated with procainamide or
acetylprocainamide [published erratum appears in N
Engl J Med, 1979; 302: 322-251] . N Engl J Med, 1979;
301: 1382-85
Article in electronic form
Drayer DE, Koffler D: Factors in the emergence
of infectious diseases. Emerg Intect Dis [serial
online]l995 Jan-Mar[cited 1996 Jun 5];1(1):[24
screens] . Available from: http: //www.cdc .gov/
uncidod/EID /eid.htm
Article, no author given
Cancer in South Africa [editorial] . S Afr Med J, 1994;
84: 15
Book, personal author( s)
Ringsven MK, Bond D: Gerontology and leadership
skills tor nurses. 2nd ed. Albany (NY): Delmar
Publishers, 1996
Book, editor(s) as author
Norman IJ, Redfern SJ, editors: Mental health care
tor elderly people. New York, Churchill Livingstone,
1996
Book, Organization as author and publisher:
Institute of Medicine (US). Looking at the future of
the Medicaid program. Washington, The Institute,
1992
Chapter in a book
Phillips SJ, Whisnant JP: Hypertension and stroke.
In: Laragh JH, Brenner BM, editors. Hypertension:
pathophysiology, diagnosis, and management. 2nd ed.
New York, Raven Press, 1995; 465-78
Conference proceedings
Kimura J, Shibasaki H, editors: Recent advances
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in clinical neurophysiology. Proceedings of the
10" International Congress of EMG and Clinical
Neurophysiology; 1995 Oct 15-19; Kyoto, Japan.
Amsterdam: Elsevier; 1996.
Conference paper
Bengtsson S, Solheim BG: Enforcement of data
protection, privacy and security in medical
intormatics. In: Lun KC, Degoulet P, Piemme TE,
Rienhoff 0, editors. MEDINFO 92. Proceedings of the
7th World Congress on Medical Informatics; 1992 Sep
6-10; Geneva, Switzerland
Avoid using abstracts or review papers as
references. Unpublished observations and personal
communications can not be used as references. It
essential, such material may be incorporated in the
appropriate place in the text.
Tables. Type or print out each table on a separate
sheet of paper. Do not submit tables as photographs.
Number tables consecutively in the order of their first
citation in the text, and supply a brie title tor each. Give
each column a short or abbreviated heading. Place
explanatory matter in footnotes, not in the heading.
Explain in footnotes all nonstandard abbreviations
that are used in each table. For footnotes use the
following symbols, in this sequence: *, t, t, §, **. etc.
Identify statistical measures of variations such as
standard deviation and standard error of the mean.
Do not use internal horizontal and vertical rules. Be
sure that each table is cited in the text.
Ifyou see data from another published or unpublished
source, obtain permission and acknowledge them
fully.
Figures should be professionally drawn and
photographed; freehand or typewritten lettering is
unacceptable. Instead of original drawings, x-ray
films, and other material, send sharp, glossy, black-
and-white photographic prints, usually 127 x 173 mm
(5 x 7 in) but no larger than 203 x 254 mm (8 x 10
in). Letters, numbers, and symbols should be clear
and even throughout and of sufficient size that when
reduced for publication each item will still be legible.
Titles and detailed explanations belong in the legends
for illustrations, not on the illustrations themselves.
Each figure should have label pasted on its back
indicating the number of the figure, author's name,
and top of the figure. Do not write on the back of
figures or scratch or mar them by using paper clips.
Do not bend figures or mount them on cardboard.
Figures should be numbered consecutively according
to the order in which they have been first cited in
the text. If a figure has been published, acknowledge
the original source and submit written permission
from the copyright holder to reproduce the material.
Permission is required irrespective of authorship
or publisher, except for documents in the public
domain.
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Photographs should be color or black & white glossy
prints with numbers and descriptions the back,
following the pattern: title, authors, number of the
photographs is description.
Photomicrographs should have internal scale markers.
Symbols, arrows, or letters used in photomicrographs
should contrast with the background. If photographs
of people are used, either the subjects must not be
identifiable or their must be accompanied by written
permission to use the photograph
Legends for illustrations. Type or print out legends
for illustrations using double-spacing, starting on a
separate page, with Arabic numerals corresponding
to the illustrations. When symbols, arrows, numbers,
or letters are used to identify parts of the illustrations ,
identify and explain each one clearly in the legend.
Explain the internal scale and identify the method of
staining in photographs.
Units of measurement. Measurements of length,
height, weight, and volume should be reported in
metric units (meter, kilogram, or liter) or their
decimal multiples. Temperatures should be given in
degrees Celsius. Blood pressures should be given in
millimeters of mercury.
Allhematologicalandclinicalchemistrymeasurements
should be reported in the metric system in terms of
the International System of Units (SI) . Alternative or
non-SI units should be added in parenthesis.
Abbreviations and symbols. Use only standard
abbreviations. Avoid abbreviations in the title and
abstract. The full term for which an abbreviation
stands should precede its first use in the text unless it
is a standard unit of measurement.
Text on a diskette. The text may be processed with
the use of any standard text editor. Standard fonts are
advised, 12-point typeface. Tables, figures, drawings
and photographs may be processed using any mode and
software (*.txt, *.doc, *.wpd, *.xIs, *.cdr, *.bmp, *.eps,
*.tif preferably). Use 3.5" diskettes, CD-R or ZIP disks.
When submitting disks, authors should (1) be certain
to include a print-out of the version of the article that
is on the disk; (2) put only the latest version of the
manuscript on the disk; (3) name the file(s) clearly; (4)
label the disk with the format of the file and the file
name; (5) provide information on the hardware and
software used. Indicate the format: IBM PC or Apple
and the name (+version) of software use.
SENDING THE MANUSCRIPT TO THE JOURNAL
The authors are requested to send 3 (three) copies of
the manuscript along with a corresponding number of
tables, pictures and photo duplicates and a computer
diskette (see below conditions) .
Send the required number of copies of the manuscript
in a heavy paper envelope, enclosing the copies
and figures in cardboard, if necessary, to prevent
photographs from being bent. Place photographs and
transparencies in a separate heavy paper envelope.
Manuscripts must be accompanied by a covering
letter signed by the first author. This must include:
1. information on prior or duplicate publication or
submission elsewhere of any part of the work as
defined earlier in this document;
2. a statement of financial or other relationships that
might lead to a conflict of interest (see below);
3. a statement that the manuscript has been read and
approved by all the authors, that the requirements
for authorship as stated earlier in this document
have been met, and that each author believes the
manuscript represents honest work; and
4. the name, address, and telephone number of
the corresponding author, who is responsible
for communicating with the other authors about
revisions and final approval of the proofs.
The letter should give any additional information
that may be helpful to the Editor, such as the type of
article in the particular journal that the manuscript
represents and whether the author would be willing to
meet the cost of reproducing color illustrations.
In stru ct i o n s for Au th ors
The manuscript must be accompanied by copies of any
permission to reproduce published material, to use
illustrations or report information about identifiable
people, or to name people for their contributions.
Authors, who have an access to Internet, can send their
work-files using standard E-Mail software. The E-mail
software must have an option to send data files attached
to the E-Mail message. In such a case all parts of the
work should be sent as separate files: text file, picture
file(s), table file(s), photo file(s) etc. To speed up the
data transfer please compress the files if possible,
using *.arj or" .zip formats before transmission.
Complete packages of manuscripts are to be sent to
the address:
Editor-In-Chief
Julian Malicki
Greater Poland Cancer Center
Garbary 15th Street
61-866 Poznan, Poland
Office: +48(61) 8850700
.Fax: +48(61)8521948
Electronic submissions: julian.malicki@wco.pl
© 2008 Greater Poland Cancer Center. All rights
reserved.
Reports of Preactical Oncology and Radiotherapy is indexed in: EMBASE, the Excerpta Medica Database, the
Elsevier BIOBASE (Current Awareness in Biological Sciences), and in the Index Copernicus.
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